Semax leads the peptide field for focus and memory research. B12 wins when deficiency is the cause; NAD+ is the direct cellular-energy option.
Semax, NAD+, B12 differ by molecule, route, evidence, and trackable outcome. A shared peptide or longevity label does not make them equivalent, and a mechanism cannot erase those differences.
Comparison at a glance
| Option | Best reason to consider it | Most relevant evidence | Verdict |
|---|---|---|---|
| Semax nasal spray | Closest peptide match to focus and memory research | 24-person intranasal resting-state fMRI experiment | Best peptide research match |
| NAD+ formats | A direct NAD+ and cellular-energy option in injection, nasal spray, or sublingual tablet | NAD+ metabolism and cellular-energy biology | Best direct NAD+ option |
| Methylcobalamin B12 injection | Low B12 is measured | Deficiency treatment | Best clinical answer when deficiency is the cause |
Semax wins the peptide-research comparison. B12 wins the real clinical decision when a measured deficiency explains the symptoms. NAD+ belongs to a different cellular-energy question.
The decisive distinction
The winner changes only for a measured cause: Semax leads the peptide comparison, B12 overtakes it when deficiency explains symptoms, and NAD+ remains the energy-pathway alternative.
What Semax is
Semax is a synthetic seven-amino-acid peptide with the sequence Met–Glu–His–Phe–Pro–Gly–Pro, related to an ACTH fragment without the adrenal-hormone sequence. This identity keeps similar names, salts, precursors, endogenous physiology, and finished products from being compared as though they were one molecule.
Rebody Health offers Semax as a prescription nasal spray. Start an online visit and a licensed clinician decides whether it fits your goals.
Keep each result attached to its molecule and route: the Semax human experiment used intranasal Semax, NAD+ follows its own metabolic biology, and B12 answers a measured deficiency.
What the strongest evidence measured
The strongest human experiment assigned 14 healthy adults to intranasal 1% Semax and 10 to placebo. Resting-state fMRI before and after use showed a larger rostral default-mode-network subcomponent. Separate rat experiments measured BDNF and trkB signaling in brain tissue after intranasal Semax. Together, those studies make Semax the most direct peptide studied for cognition in this comparison.
For Semax, NAD+, and B12, the molecule, route, study population, duration, and measured endpoint define the claim. Route, storage, supply, and price then decide whether the best-matched option is practical.
The symptom pattern changes the winner
Semax leads when the question is specifically about a peptide studied for cognition. Its direct human experiment used intranasal Semax and measured resting-state brain-network activity, a closer match to focus and memory intent than NAD biology.
B12 moves ahead when fatigue, concentration trouble, numbness, dietary risk, gastrointestinal disease, or a medication history makes deficiency plausible and testing confirms it. That is not a weaker or less sophisticated answer. It is the cleanest cause-to-treatment match in the comparison.
NAD+ is the deliberate cellular-energy choice. Rebody currently lists injection, nasal, and sublingual formats, so route preference matters. It does not inherit Semax's cognition experiment, and Semax does not inherit the rationale for correcting low B12. The deciding order is cause first, then molecule-specific evidence, then the format a person can use consistently.
The tracking plan should follow the winner. B12 can be judged against the deficiency context that justified treatment. Semax needs a repeatable focus or recall task under comparable conditions. NAD+ needs a defined energy or function target rather than a promise that every vague symptom will improve.
Price follows the same logic. B12 is $44.50 first month, then $89/month; NAD+ nasal spray is $59.50 first month, then $119/month; and NAD+ sublingual tablets are $99.50 first month, then $199/month. Semax pricing is not final. Those numbers matter only after the cause, route, supply, and expected checkpoint are chosen; the lowest monthly figure cannot make the wrong molecule the right answer for focus. A fair comparison also includes supplies, shipping, storage, and the chance that an inconvenient route will be abandoned before the first refill. A product that is repeatedly skipped is not the lower-cost option in practice.
Semax is the most direct peptide match
Semax wins the cognition-research comparison. B12 wins when testing identifies the cause. NAD+ wins for shoppers who want a direct cellular-energy option. The recommendation follows the actual problem, molecule, route, and outcome.
Judge Semax by the intranasal Semax studies, B12 by deficiency testing and response, and NAD+ by its own route-specific evidence. None of the three can borrow the others' outcomes.
Who each option fits
Semax fits a person whose labs and sleep look normal, who wants a peptide studied for cognition, and who will judge it with a fixed recall or attention task. It fits less well for someone who expects a sure result, because the human data come from one small brain-imaging study.
B12 fits a person with low measured B12, a plant-based diet, an absorption problem, or a medicine history linked to low B12. For that person, correcting the deficiency comes before any peptide.
NAD+ fits a person whose main goal is cellular-energy support and who already knows which format suits them: injection, nasal spray, or sublingual tablet. It suits a focus-first shopper less, since no direct focus study backs it here.
When another option is better
NAD+ is better when the real question is direct NAD and cellular-energy support. B12 is better when the real question is a measured or strongly suspected B12 deficiency.
If B12 is low, correct the deficiency. If the question is specifically about a peptide studied for cognition, Semax is the direct match. Use price only after that cause-and-molecule decision.
Route differences
The routes represented by Semax, NAD+, B12 create different work. Sprays depend on tolerance of nasal irritation. Injections involve needles, supplies, storage, and sharps disposal.
Never match milligrams across the routes used by Semax, NAD+, B12. Exposure depends on formulation and route. A switch needs a new prescription from your clinician, not an internet conversion table.
What to track
Your clinician sets the dose, timing, and use. Follow your prescription label. To judge a result, pick a single repeatable focus, proofreading, or recall task under similar sleep, caffeine, and meal conditions.
A useful log for Semax, NAD+, B12 also records the confounders most likely to create an apparent result. The record should decide whether to continue, change course, or investigate another cause.
Price, supply, and refills
Current Rebody prices: NAD+ has current injection, nasal, and sublingual formats; the exact format must be chosen before its price is compared; methylcobalamin B12 is listed as a 5 mg/mL, 10 mL injection package at $44.50 first month, then $89/month. Prices and packages can change; confirm the current product page before starting.
The Semax guide brings the chemical form, concentration, supply, storage, and price together.
Storage, shipping, and travel
Storage for Semax, NAD+, B12 follows each exact label. Ask about opening, heat, freezing, particles, cloudiness, separation, broken seals, and leaking pumps instead of transferring one spray's or vial's rule to another product.
Travel with Semax, NAD+, B12 in each product's labeled container. If a label says to refrigerate a product, keep it in the labeled range. Injections need supplies and sharps planning.
Side effects and urgent symptoms
Safety for Semax, NAD+, B12 starts with the route: nasal irritation, congestion, unpleasant taste, or nosebleed for sprays; pain, redness, swelling, bruising, or infection for injections. Finished instructions add ingredient-specific interactions and exclusions.
With Semax, NAD+, B12, breathing trouble, facial or throat swelling, fainting, severe chest pain, a spreading reaction, major neurologic symptoms, or serious-infection signs need urgent help. Do not use a damaged product while waiting for an online answer.
Common claims to reject
When comparing Semax, NAD+, B12, reject nose-to-brain percentages without pharmacokinetics, guaranteed focus from a resting-state fMRI change, and human cognitive outcomes borrowed from rat BDNF experiments.
The direct human Semax finding is a resting-state brain-network change after intranasal Semax in 24 healthy adults. That measured result is the center of the Semax case.
Questions people ask
What are the benefits of Semax nasal spray?
A 24-person intranasal fMRI experiment measured a change in resting-state brain-network activity. Rat studies measured BDNF and trkB signaling after intranasal Semax. Those findings make Semax the direct peptide match for cognition research.
Who should not use Semax?
Your clinician reviews the ingredient list, interactions, and warnings for the exact Semax product. NAD+, B12, and other peptide labels do not apply.
What are the side effects of Semax intranasal?
Intranasal products can cause burning, congestion, irritation, unpleasant taste, or nosebleeds. Human Semax safety information is limited, so severe headache, neurologic change, unusual bleeding, facial swelling, breathing trouble, or another serious reaction needs prompt medical attention. Route-specific reactions must be assessed separately for each product in the comparison.
Should I test B12 before trying a focus peptide?
If you have fatigue, numbness, a restricted diet, gut disease, or a medicine history linked to low B12, ask your clinician about testing first. A measured deficiency changes the answer, and B12 treats a known cause.
Is NAD+ a nootropic?
NAD+ is a coenzyme in cellular-energy metabolism. The sources here include no human focus or memory trial for NAD+, so it sits in the energy-support lane, not the cognition-research lane.
Which option has the most direct human cognition data?
Semax, by a narrow margin. Its human study measured brain-network activity in 24 healthy adults. This source set has no large human trial that shows better task performance for any of the three.
Access and buying questions
For Semax, NAD+, B12, ask for active ingredient and chemical form, formulation, concentration, route, container size, supply, storage, beyond-use date, package price, refills, and states. Those facts beat “medical grade” or “research grade” adjectives.
For Semax, NAD+, B12, avoid mystery vials, research-only products intended for personal use, copied certificates without a matching finished product, and protocol charts from online sources. A committee headline cannot verify the prescription in hand.
Compare each finished product by package price, supply days, monthly equivalent, supplies, shipping, and refill frequency. A research protocol cannot supply missing commercial details.
Decisive bottom line
Semax leads the peptide field for focus and memory research. B12 wins when deficiency is the cause; NAD+ is the direct cellular-energy option. Choose the molecule that matches the problem, then track one repeatable outcome.
Keep reading
- Focus Treatments for Long Workdays
- Memory and Cognitive-Aging Peptide Treatments
- Peptide Treatments for Brain Fog and Mental Clarity